Sol-Gel Technologies Ltd. (SLGL)
SLGL Stock Price Chart
Explore Sol-Gel Technologies Ltd. interactive price chart. Choose custom timeframes to analyze SLGL price movements and trends.
SLGL Company Profile
Discover essential business fundamentals and corporate details for Sol-Gel Technologies Ltd. (SLGL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Feb 2018
Employees
34.00
Website
https://www.sol-gel.comCEO
Moshe Arkin
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has completed Phase III clinical trials for the treatment of acne vulgaris; Epsolay, a once-daily topical cream that has completed Phase III clinical trials for the treatment of papulopustular rosacea; SGT-210, which is in Phase I clinical trial for the treatment of palmoplantar keratoderma; and Erlotinib, Tapinarof, and roflumilast to treat psoriasis and other medical conditions. It is also involved in the development of generic topical dermatological drug products. The company has collaboration with Perrigo. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
SLGL Financial Timeline
Browse a chronological timeline of Sol-Gel Technologies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 21 May 2026
Upcoming earnings on 14 Nov 2025
Earnings released on 15 Aug 2025
EPS came in at $4.17 surpassing the estimated -$0.67 by +722.39%, while revenue for the quarter reached $17.26M , beating expectations by +504.00%.
Stock split effective on 5 May 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Apr 2025
EPS came in at -$2.10 falling short of the estimated -$1.10 by -90.91%, while revenue for the quarter reached $1.03M , missing expectations by -48.45%.
Earnings released on 26 Mar 2025
EPS came in at -$0.21 falling short of the estimated -$0.11 by -90.77%, while revenue for the quarter reached $278.00K , missing expectations by -86.10%.
Earnings released on 15 Nov 2024
EPS came in at -$0.01 surpassing the estimated -$0.13 by +92.31%, while revenue for the quarter reached $5.36M , beating expectations by +168.05%.
Earnings released on 16 Aug 2024
EPS came in at $0.07 surpassing the estimated -$0.20 by +135.00%, while revenue for the quarter reached $5.43M , beating expectations by +417.43%.
Earnings released on 20 May 2024
EPS came in at -$0.23 falling short of the estimated -$0.15 by -53.33%, while revenue for the quarter reached $466.00K , missing expectations by -49.89%.
Earnings released on 13 Mar 2024
EPS came in at -$0.17 falling short of the estimated -$0.16 by -6.25%, while revenue for the quarter reached $447.00K , beating expectations by +65.56%.
Earnings released on 9 Nov 2023
EPS came in at -$0.21 surpassing the estimated -$0.23 by +8.70%, while revenue for the quarter reached $213.00K , missing expectations by -21.11%.
Earnings released on 10 Aug 2023
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $594.00K , missing expectations by -61.68%.
Earnings released on 12 May 2023
EPS came in at -$0.41 falling short of the estimated -$0.22 by -86.36%, while revenue for the quarter reached $758.00K , beating expectations by +61.28%.
Earnings released on 10 Mar 2023
EPS came in at -$0.25 falling short of the estimated -$0.13 by -92.31%, while revenue for the quarter reached $100.00K , missing expectations by -94.57%.
Earnings released on 10 Nov 2022
EPS came in at -$0.15 falling short of the estimated -$0.07 by -114.29%, while revenue for the quarter reached $261.00K , missing expectations by -92.38%.
Earnings released on 4 Aug 2022
EPS came in at -$0.01 surpassing the estimated -$0.10 by +90.00%, while revenue for the quarter reached $3.52M , missing expectations by -23.68%.
Earnings released on 13 May 2022
EPS came in at -$0.24 surpassing the estimated -$0.30 by +20.00%, while revenue for the quarter reached $3.00K , missing expectations by -99.78%.
Earnings released on 30 Mar 2022
EPS came in at $0.61 surpassing the estimated $0.41 by +48.78%, while revenue for the quarter reached $20.81M , beating expectations by +17.86%.
Earnings released on 11 Nov 2021
EPS came in at $0.05 surpassing the estimated -$0.07 by +171.43%, while revenue for the quarter reached $8.84M , missing expectations by -62.96%.
Earnings released on 4 Aug 2021
EPS came in at -$0.35 falling short of the estimated -$0.20 by -75.00%, while revenue for the quarter reached $928.00K , beating expectations by +7.74%.
Earnings released on 13 May 2021
EPS came in at -$0.18 surpassing the estimated -$0.49 by +63.27%, while revenue for the quarter reached $701.00K , missing expectations by -30.56%.
Earnings released on 4 Mar 2021
EPS came in at -$0.36 surpassing the estimated -$0.41 by +12.20%, while revenue for the quarter reached $2.06M .
Earnings released on 12 Nov 2020
EPS came in at -$0.37 surpassing the estimated -$0.43 by +13.95%, while revenue for the quarter reached $2.12M , missing expectations by -16.36%.
SLGL Stock Performance
Access detailed SLGL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.